Fast Market Research recommends "Gamma Therapeutics, Inc. - Product Pipeline Analysis, 2013 Update" from GlobalData, now available

Boston, MA -- (SBWire) -- 02/11/2014 --Gamma Therapeutics, Inc. (Gamma Therapeutics) is a biotechnology company. The company develops biopharmaceutical and diagnostic solutions for cardiovascular disease risk assessment, surgical therapy and combat casualty care. Its products include GammaCoeur, GammaSeal and Gammarin. The company's GammaCoeur is a cardiovascular disease diagnostic assay for prognosis and preventative care. Gamma Therapeutics GammaSeal is a natural surgical sealant for large artery vascular surgery and Gammarin, a non-immunogenic anti-coagulant blood thinner for post-surgical venous thromboembolism control which is currently under development. Its products are based on gamma prime fibrinogen, a natural occurring clotting protein. Gamma Therapeutics is headquartered in Portland, Oregon, the US.

View Full Report Details and Table of Contents

This report is a source for data, analysis and actionable intelligence on the Gamma Therapeutics, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date.

Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments.
- Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase.
- Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date.
- Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application.
- Data on relevant clinical trials and product patent details, wherever applicable.
- Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility.

Reasons to Get This Report

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape globally.

Companies Mentioned in this Report: Gamma Therapeutics, Inc.

About Fast Market Research
Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Medical Devices research reports at Fast Market Research

You may also be interested in these related reports:

- Cytori Therapeutics, Inc. (CYTX) - Product Pipeline Analysis, 2013 Update
- Anika Therapeutics, Inc. (ANIK) - Product Pipeline Analysis, 2013 Update
- BioMimetic Therapeutics, Inc. - Product Pipeline Analysis, 2013 Update
- InVivo Therapeutics Corporation - Product Pipeline Analysis, 2013 Update
- ImmunoCellular Therapeutics, Ltd. (IMUC) - Product Pipeline Analysis, 2013 Update
- SPR Therapeutics - Product Pipeline Analysis, 2013 Update
- Amorfix Life Sciences Ltd. (AMF) - Product Pipeline Analysis, 2013 Update
- OPKO Health, Inc. (OPK) - Product Pipeline Analysis, 2013 Update
- Rosetta Genomics, Ltd. (ROSG) - Product Pipeline Analysis, 2013 Update
- Epistem Holdings Plc (EHP) - Product Pipeline Analysis, 2013 Update